Abstract |
PURPOSE: PATIENTS AND METHODS: We evaluated 1 eye each of 68 glaucoma patients who were treated with at least 1 prostaglandin analog. Their baseline MD slopes were < -0.5 dB/y based on at least 5 Humphrey field analyzer measurements within 3 years. Eligible eyes were randomly assigned to brimonidine or timolol treatment groups and treatments were administered without the wash-out period. Clinical examinations were performed every 4 months for 2 years. We designated the MD slope as the primary endpoint. RESULTS: Ultimately, 56 eyes ( brimonidine: timolol=26:30) were included in the present study (mean age=65.2 y). Dropout rates of brimonidine and timolol treatment groups were 27.8% and 6.3%, respectively. There were no significant differences in baseline intraocular pressure or MD slopes between brimonidine and timolol groups (12.7 and 12.9 mm Hg, P=0.77, and -1.22 and -1.08 dB/y, P=0.43, respectively). Intraocular pressure decreased significantly in the brimonidine group at 4, 8, 12, and 16 months, and in the timolol group at 4 months, without significant differences between the drugs (P=0.20). MD slopes significantly improved in both groups ( brimonidine: -0.38 dB/y, P<0.001; timolol: -0.52 dB/y, P=0.04). Furthermore, there was no significant difference between groups in the primary endpoint (P=0.59). CONCLUSION:
|
Authors | Yu Yokoyama, Ryo Kawasaki, Hidetoshi Takahashi, Shigeto Maekawa, Satoru Tsuda, Kazuko Omodaka, Toru Nakazawa |
Journal | Journal of glaucoma
(J Glaucoma)
Vol. 28
Issue 7
Pg. 575-583
(07 2019)
ISSN: 1536-481X [Electronic] United States |
PMID | 31188229
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antihypertensive Agents
- Brimonidine Tartrate
- Timolol
|
Topics |
- Aged
- Antihypertensive Agents
(therapeutic use)
- Brimonidine Tartrate
(therapeutic use)
- Disease Progression
- Double-Blind Method
- Female
- Glaucoma, Open-Angle
(diagnosis, drug therapy, physiopathology)
- Humans
- Intraocular Pressure
(drug effects)
- Male
- Middle Aged
- Prospective Studies
- Timolol
(therapeutic use)
- Tonometry, Ocular
- Vision Disorders
(diagnosis, drug therapy, physiopathology)
- Visual Field Tests
- Visual Fields
(drug effects)
|